Eastern, a fifth-year senior from Shakopee, has developed into a defensive tackle who has been a three-year starter for the ...

The settlement ends a 2023 lawsuit alleging pharmaceutical companies manipulated ADHD medication quality tests.

In October, Pharmac announced its decision to fund the Sandoz XR brand of methylphenidate. In December 2024, it began funding lisdexamfetamine to improve supply and provide more options for ADHD ...

A new study suggests the connection between Attention-Deficit/Hyperactivity Disorder (ADHD) and the body’s primary stress ...

(Reuters) -The founder and a former top doctor at Done Global were convicted by a San Francisco jury of conspiring to distribute Adderall and other stimulants, in the first federal prosecution of ...

Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to ​resolve a lawsuit claiming they defrauded ...

In two newly published studies, researchers at the Department of Ethology, Eötvös Loránd University (Hungary) investigated ...

Pfizer Inc. and Tris Pharma Inc. will pay the state of Texas $41.5 million to settle claims that it allegedly provided ...

Attention deficit hyperactivity disorder (ADHD) is the most common disability diagnosis in children globally. It's estimated ...

Pfizer (PFE) stock is in focus as the firm joins Tris Pharma to settle a lawsuit over supplying an adulterated ADHD drug to ...

Attention deficit hyperactivity disorder (ADHD) is the most common disability diagnosis in children globally. It's estimated to affect around 8% ...